Replies to post #41162 on Ayala Pharmaceuticals Inc (ADXS)

[abuhafsa]

Absolutely agree. It isn't a level playing field and the tools they have at their disposal are very powerful. But in the long term it doesn't matter if any company is growing revenue and profits and beating market expectations.

The PPS was higher 5 years ago because of the hype and expectation of future revenue and profit. That hasn't materialized. All we have is great science but risk that the company will not be able to get it past the finish line and make a profitable business out of it. Even after EMA and FDA approval, the company has to convince investors that it has a solid plan in place to generate revenue and profits from the science without further dilution.

For any company, show me revenue and profit growth quarter after quarter and the PPS will rise.

Advaxis is a business, not a government run science lab. They can all win 5 nobel prizes in biology it wouldn't matter if the company is not generating profit, or has the expectation of generating profits in the near term.

All the talk about HFT and manipulation is useless.

[mm2k]

The risk profile of failure may be lower than 5 years ago, but probably much higher than 1-2 years ago, and that's largely why the stock has gotten pummeled. It's a higher risk because the financial runway is much shorter, but the potential rewards are also much greater at this point, but even those still have some risk. Meaning the rewards are not completely guaranteed even if the financial problems are solved.